1 active alert Show

Breast Cancer Research Program

Community Research Advisory Board

Identifying issues of critical importance to our community.

Building Networks Throughout Our Community

ChristianaCare’s Community Research Advisory Board brings together breast cancer survivors, community leaders and health care experts to advance scientific discovery.

Members bring their unique perspective to the table to identify issues of critical importance to our community for translational cancer research teams at the Helen F. Graham Cancer Center, and build networks throughout our community to educate neighbors about cancer risk assessment, prevention, early detection, treatment options and clinical research trials.

Successful group of female cancer survivors from the community.

One of the first challenges identified by the Community Research Advisory Board is Delaware’s very high incidence of Triple Negative Breast Cancer, especially among African-American women.

To help community health ambassadors educate women about this aggressive form of breast cancer, they created The Story of BRENDA — a free community education program. The acronym BRENDA helps women remember key steps they can take to reduce their risk for Triple Negative Breast Cancer:

  • Breastfeed
  • Reduce alcohol
  • Exercise
  • Nutritious foods
  • Don’t smoke
  • Achieve a healthy body weight

Call 302-623-4661 or complete the request form to schedule a speaker today for your faith, professional or community group!

If you would like to be part of the Community Research Advisory Board to promote education and awareness in our community about breast cancer health and research, contact us at translationalresearch@christianacare.org. Members are asked to participate in up to three in-person evening meetings per year.

Related Content

Cancer treatment is hard enough without having to make trips to the Emergency Department (ED) due to complications from treatment.
What’s My Risk of Developing Breast Cancer?

Contact Us

Cancer Research Program

Helen F. Graham Cancer Center & Research Institute
4701 Ogletown-Stanton Road, Suite 2200,
Newark, DE 19713